Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Lilly licenses non-opioid pain therapeutic from Centrexion

medication
CNTX-0290 is currently undergoing Phase I clinical trials as a potential non-opioid therapy to treat chronic pain. Credit: newsong from Pixabay.